Inicio › Leucemia mielógena crónica › Texas › Houston
Ensayos clínicos de Leucemia mielógena crónica en Houston, TX
18 estudios para Leucemia mielógena crónica buscan participantes en centros de Houston y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
ReclutandoFase 2
- M D Anderson Cancer Center, Houston
Asciminib Roll-over Study
ReclutandoFase 4
- Uni Of TX MD Anderson Cancer Cntr, Houston
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- UT MD Anderson Cancer Center, Houston
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
ReclutandoFase 2
- MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
ReclutandoEstudio observacional
- Texas Children's Hospital, Houston
TGRX-678 US Phase I for Chronic Myelogenous Leukemia Patients
ReclutandoFase 1
- The University of Texas MD Anderson Cancer Center, Houston
A Clinical Study of MK-4208/TERN-701 in Participants With Chronic Myeloid Leukemia (CML) (MK-4208-003/Tern701-1012/CARDINAL)
ReclutandoFase 1/2
- The University of Texas M.D. Anderson Cancer Center, Houston
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
ReclutandoFase 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
ReclutandoEstudio observacional
- University of Texas MD Anderson Cancer Center, Houston
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
ReclutandoFase 2
- MD Anderson Cancer Center, Houston
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
ReclutandoFase 1
- M D Anderson Cancer Center, Houston
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
ReclutandoFase 2
- M D Anderson Cancer Center, Houston
Study of Olverembatinib (HQP1351) in Patients With CML-CP
ReclutandoFase 3
- Ascentage Investigative Site #1501, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
ReclutandoEstudio observacional
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
ReclutandoFase 1
- The University of Texas MD Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
ReclutandoFase 2
- MD Anderson, Houston
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
ReclutandoFase 1
- MD Anderson Cancer Center, Houston
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
ReclutandoFase 1
- University of Texas MD Anderson Cancer Center, Houston
Más información sobre Leucemia mielógena crónica en MedlinePlus
Ensayos de Leucemia mielógena crónica en otras ciudades
- Seattle, WA11 estudios
- New York City, NY10 estudios
- Portland, OR7 estudios
- Baldwin Park, CA7 estudios
- Chicago, IL7 estudios
- Detroit, MI6 estudios
- Birmingham, AL6 estudios
- Philadelphia, PA6 estudios
- St. Louis, MO6 estudios
- Milwaukee, WI5 estudios
- Nashville, TN5 estudios
- Atlanta, GA5 estudios
Otros estudios en Houston
- Cáncer de pulmón de células no pequeñas143 estudios
- Cáncer de seno126 estudios
- Cáncer (todos los tipos)124 estudios
- Cáncer del colon y del recto101 estudios
- Cáncer metastásico100 estudios
- Cáncer de ovario90 estudios
- Leucemia mielógena aguda88 estudios
- Cáncer de pulmón78 estudios
- Cáncer de próstata73 estudios
- Cáncer de endometrio69 estudios
- Melanoma61 estudios
- Cáncer de páncreas59 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.